approval
saveBLUJEPA (GEPOTIDACIN MESYLATE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN) — FDA approvalDec 9, 2025
- approvalSUMATRIPTAN SUCCINATE: IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025
- approvaldepemokimab: EXDENSUR (DEPEMOKIMAB-ULAA) — FDA approvalDec 16, 2025
- approvalFLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approvalDec 19, 2025
- approvalALBUTEROL SULFATE — FDA approvalDec 1, 2025
comments(0)
5-min edit window · permanent after that